Clinical
New clinical trial registered for Semaglutide
Related compound: SemaglutideView source →
Semaglutide for Treatment of People With Methamphetamine Use Disorder: the SHIFT Study (NCT07509112) registered on ClinicalTrials.gov. Phase: phase 2. Status: not yet recruiting.